GSK plc vs Roundhill Russell 2000 0DTE Covered Call Strat ETF — how do they compare? GSK plc trades at $46.82 (market cap $91.88B), while Roundhill Russell 2000 0DTE Covered Call Strat ETF trades at $26.04 (market cap $159.33M). The key difference: GSK plc is far larger — about 576.7× Roundhill Russell 2000 0DTE Covered Call Strat ETF's market cap, and GSK plc pays a 3.9% dividend while Roundhill Russell 2000 0DTE Covered Call Strat ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and Roundhill Russell 2000 0DTE Covered Call Strat ETF for 53 Days on average.
| GSK | RDTE | |
|---|---|---|
Market Cap | $91.88B | $159.33M |
Volume | 7,730,529 | 248,058 |
Sector | Health | Income / Options Overlay |
52-Week High | $61.18 | $33.66 |
52-Week Low | $43.24 | $25.96 |
Typical Hold Time | 93 Days | 53 Days |
Enterprise Value | $111.88B | — |
Dividend Yield | 3.9% | — |
Signals from Pluang's Aura AI — not financial advice
GSK trades at $47.02, up 0.9% with a P/E of 14.89, trading below industry averages. The stock shows strong profitability with 72.73% gross margins and 29.73% ROE, though technical indicators signal bearish momentum. Recent earnings beats and strategic oncology investments highlight growth potential amid patent cliff concerns.
GSK's valuation appears attractive with earnings momentum, but faces headwinds from technical weakness and HIV patent expirations. The bullish analyst sentiment (31% buy ratings) and pipeline innovation provide upside, while cost-saving initiatives and dividend yield offer stability. Key risks include competitive pressures and execution on £40B sales targets.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →RDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the Russell 2000 Index. The fund primarily holds a portfolio of short-term U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the Russell 2000. This highly tactical strategy aims to maximize premium capture by exploiting the high time decay of options that are expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on RDTE →